Cargando…

Review of guidelines on the treatment of metastatic renal cell carcinoma

Guidelines on the management of metastatic renal cell carcinoma (rcc) have emerged over the last couple of years because of the introduction of effective new targeted therapies. However, current guidelines are not always contemporary because of older data whose relevance is unclear in the context of...

Descripción completa

Detalles Bibliográficos
Autor principal: Soulières, D.
Formato: Texto
Lenguaje:English
Publicado: Multimed Inc. 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687806/
https://www.ncbi.nlm.nih.gov/pubmed/19478902
_version_ 1782167597045776384
author Soulières, D.
author_facet Soulières, D.
author_sort Soulières, D.
collection PubMed
description Guidelines on the management of metastatic renal cell carcinoma (rcc) have emerged over the last couple of years because of the introduction of effective new targeted therapies. However, current guidelines are not always contemporary because of older data whose relevance is unclear in the context of the new therapies. Moreover, many of the relevant trials were interrupted prematurely because of significant advantages in progression-free survival. These circumstances sometimes make interpretation of the data and characterization of subgroups rather difficult. The current paper reviews the major guidelines available on the management of metastatic rcc and tries to put them into context.
format Text
id pubmed-2687806
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Multimed Inc.
record_format MEDLINE/PubMed
spelling pubmed-26878062009-05-28 Review of guidelines on the treatment of metastatic renal cell carcinoma Soulières, D. Curr Oncol Urologic Oncology Guidelines on the management of metastatic renal cell carcinoma (rcc) have emerged over the last couple of years because of the introduction of effective new targeted therapies. However, current guidelines are not always contemporary because of older data whose relevance is unclear in the context of the new therapies. Moreover, many of the relevant trials were interrupted prematurely because of significant advantages in progression-free survival. These circumstances sometimes make interpretation of the data and characterization of subgroups rather difficult. The current paper reviews the major guidelines available on the management of metastatic rcc and tries to put them into context. Multimed Inc. 2009-05 /pmc/articles/PMC2687806/ /pubmed/19478902 Text en 2009 Multimed Inc. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Urologic Oncology
Soulières, D.
Review of guidelines on the treatment of metastatic renal cell carcinoma
title Review of guidelines on the treatment of metastatic renal cell carcinoma
title_full Review of guidelines on the treatment of metastatic renal cell carcinoma
title_fullStr Review of guidelines on the treatment of metastatic renal cell carcinoma
title_full_unstemmed Review of guidelines on the treatment of metastatic renal cell carcinoma
title_short Review of guidelines on the treatment of metastatic renal cell carcinoma
title_sort review of guidelines on the treatment of metastatic renal cell carcinoma
topic Urologic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687806/
https://www.ncbi.nlm.nih.gov/pubmed/19478902
work_keys_str_mv AT soulieresd reviewofguidelinesonthetreatmentofmetastaticrenalcellcarcinoma